Brainstorm Cell Therapeutics Inc. SEC filings BCLI
Brainstorm Cell Therapeutics Inc. has 949 filings in SEC EDGAR's recent list, going back to May 24, 2001. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 30, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| 3 | Initial insider ownership | Jun 3, 2026 | May 25, 2026 |
| EFFECT | Filing | Jun 2, 2026 | — |
| CORRESP | Letter to the SEC | Jun 1, 2026 | — |
| 4 | Insider transaction | May 29, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 29, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 29, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 29, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 29, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 28, 2026 | May 25, 2026 |
| UPLOAD | Letter from the SEC | May 27, 2026 | — |
| S-8 | Employee stock plan registration | May 21, 2026 | — |
| S-1 | Registration statement | May 21, 2026 | — |
| 4 | Insider transaction | May 20, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 20, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 20, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 20, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 20, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | May 20, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Feb 27, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 13, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 9, 2026 | Jan 5, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Nov 14, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 6, 2025 | Oct 31, 2025 |
| 25-NSE | Delisting notice | Oct 9, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| RW | Filing | Jul 22, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jul 17, 2025 | Jul 16, 2025 |
| S-8 | Employee stock plan registration | Jul 3, 2025 | — |
| S-3 | Shelf registration | Jun 25, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 19, 2025 |
| ARS | Annual report to shareholders | May 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 16, 2025 | — |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 25, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 21, 2025 | Apr 20, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 27, 2025 | Mar 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jan 21, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 15, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 1, 2025 |
| 3/A | Ownership document | Jan 7, 2025 | Apr 17, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 1, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2024 | — |
| 8-K |
Current report
Listing notice
|
Oct 30, 2024 | Oct 29, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change
|
Oct 1, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| EFFECT | Filing | Sep 27, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 26, 2024 | Sep 26, 2024 |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| S-3/A | Form s-3/a | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2024 | — |
| S-3 | Shelf registration | Sep 17, 2024 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Sep 16, 2024 | Sep 16, 2024 |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| S-3 | Shelf registration | Aug 28, 2024 | — |
| ARS | Annual report to shareholders | Aug 16, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Aug 16, 2024 | Sep 16, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| PRER14A | Filing | Aug 6, 2024 | — |
| PRE 14A | Preliminary proxy statement | Aug 5, 2024 | Sep 16, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | May 28, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | May 21, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | May 10, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | May 7, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | May 6, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | Apr 19, 2024 |
| 4/A | Ownership document | Jul 31, 2024 | Apr 17, 2024 |
| 8-K | Current report | Jul 30, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 19, 2024 | Jul 18, 2024 |
| 424B5 | Prospectus supplement | Jun 28, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 28, 2024 | Jun 27, 2024 |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 25, 2024 | Jun 24, 2024 |
| 3 | Initial insider ownership | Jun 25, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 20, 2024 | Jun 19, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 4, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 7, 2024 | May 7, 2024 |
| 4 | Insider transaction | May 7, 2024 | May 6, 2024 |
| 8-K |
Current report
Listing notice
|
May 3, 2024 | May 1, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 19, 2024 |
| 3 | Initial insider ownership | Apr 22, 2024 | Apr 17, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 17, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Apr 9, 2024 |
| 424B5 | Prospectus supplement | Apr 2, 2024 | — |
| 8-K |
Current report
Material agreement
|
Apr 2, 2024 | Apr 2, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 13, 2024 | Mar 11, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure, Other events
|
Dec 20, 2023 | Dec 18, 2023 |
| DEFA14A | Additional proxy material | Nov 22, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 22, 2023 | Nov 20, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 9, 2023 | Nov 6, 2023 |
| DEF 14A | Proxy statement | Nov 8, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 3, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Oct 24, 2023 | Oct 18, 2023 |
| 4 | Insider transaction | Sep 5, 2023 | Sep 1, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 4 | Insider transaction | Aug 7, 2023 | Aug 2, 2023 |
| 4 | Insider transaction | Aug 4, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 19, 2023 | Jul 17, 2023 |
| 424B5 | Prospectus supplement | Jul 19, 2023 | — |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 3 | Initial insider ownership | Jun 21, 2023 | Jun 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change
|
May 24, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 1, 2023 | May 1, 2023 |
| 3 | Initial insider ownership | May 1, 2023 | May 1, 2023 |
| 4 | Insider transaction | Apr 24, 2023 | Apr 20, 2023 |
| 4 | Insider transaction | Apr 24, 2023 | Apr 20, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 5, 2023 | — |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jan 11, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 4, 2023 | Jan 3, 2023 |
| 4 | Insider transaction | Jan 4, 2023 | Dec 7, 2022 |
| 4 | Insider transaction | Jan 4, 2023 | Sep 18, 2022 |
| DEF 14A | Proxy statement | Dec 13, 2022 | Jan 10, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2022 | Oct 7, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Sep 22, 2022 | Sep 18, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 4 | Insider transaction | Apr 8, 2022 | Apr 6, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 4 | Insider transaction | Mar 14, 2022 | Mar 6, 2022 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 4, 2022 | — |
| 4 | Insider transaction | Feb 3, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2022 | Nov 15, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 17, 2021 | Dec 14, 2021 |
| 4 | Insider transaction | Dec 17, 2021 | Dec 15, 2021 |
| 4 | Insider transaction | Dec 17, 2021 | Dec 15, 2021 |
| 4 | Insider transaction | Dec 17, 2021 | Dec 15, 2021 |
| 4 | Insider transaction | Dec 17, 2021 | Dec 15, 2021 |
| 4 | Insider transaction | Dec 17, 2021 | Dec 15, 2021 |
| 4 | Insider transaction | Dec 10, 2021 | Dec 10, 2021 |
| 4 | Insider transaction | Dec 10, 2021 | Dec 10, 2021 |
| 4 | Insider transaction | Dec 10, 2021 | Dec 10, 2021 |
| 4 | Insider transaction | Dec 10, 2021 | Dec 10, 2021 |
| 4 | Insider transaction | Dec 10, 2021 | Dec 10, 2021 |
| 4 | Insider transaction | Dec 10, 2021 | Dec 10, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCLI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1137883
- Former names
- BRAINSTORM CELL THERAPEUTICS INC (until Jul 23, 2012); GOLDEN HAND RESOURCES INC (until Nov 22, 2004); WIZBANG TECHNOLOGIES INC (until Aug 8, 2003)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.